{"url_path":"/sec/sonm/8-k/2026-07-02/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 ****Unregistered","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-031675-index.html","accession_number":"0001493152-26-031675","cik":"0001178697","ticker":"SONM","issuer_name":"DNA X, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-031675-index.html","primary_entity_key":"0001178697","primary_entity_name":"DNA X, Inc."},"word_count":79,"has_tables":true,"body_markdown":"**Item\n3.02****Unregistered\nSales of Equity Securities.**\n\n \n\nThe\ninformation contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02. The Series B Preferred Stock will\nbe issued and sold, and the underlying shares of Common Stock will be issued, without registration under the Securities Act\nin reliance on the exemptions provided by Section 4(a)(2) of the Securities Act and Rule 506 promulgated under the Securities Act and\nin reliance on similar exemptions under applicable state laws."}